The particle size of a vaccine has a considerable influence on its half-life in vivo, as well as on
its uptake by antigen-presenting cells.
Here we use the Litesizer to characterize the particle size and the zeta potential of vaccines against COVID-19, tick-borne encephalitis and influenza.
Download this report now to find out more.
Please contact us at info.gb@anton-paar.com or visit our website for further information.
Anton Paar Ltd
Tel: +44(0)1992514730
info.gb@anton-paar.com
www.anton-paar.co.uk
Click here and register to access technical articles and white papers from this company
JLR teams with Allye Energy on portable battery storage
This illustrates the lengths required to operate electric vehicles in some circumstances. It is just as well few electric Range Rovers will go off...